1999
DOI: 10.1016/s0009-9236(99)70013-5
|View full text |Cite
|
Sign up to set email alerts
|

Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706

Abstract: Significant increases of Cmax and ka and reductions of tmax and elimination t1/2 of the inhaled FK706 were observed in the healthy smokers, suggesting that the smoking habit accelerates the drug absorption after inhalation. These results suggest that we should pay attention to the drug-related adverse events caused by smoking, especially when the drug has a narrow therapeutic range.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 24 publications
(33 reference statements)
0
5
0
Order By: Relevance
“…Interestingly, the smokers demonstrated a shorter t max and a shorter elimination half-life (1.23 ± 0.40 h vs 2.73 ± 0.57 h, respectively) [148]. k a was reported to be ten-times greater in smokers than nonsmokers.…”
Section: Drug Examplesmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, the smokers demonstrated a shorter t max and a shorter elimination half-life (1.23 ± 0.40 h vs 2.73 ± 0.57 h, respectively) [148]. k a was reported to be ten-times greater in smokers than nonsmokers.…”
Section: Drug Examplesmentioning
confidence: 99%
“…These findings may suggest that smoking causes increasing pulmonary epithelial permeability. FK706 is a small hydrophilic molecule and this phenomenon could apply to other xenobiotics that are delivered to the lungs with similar physicochemical properties [148]. …”
Section: Drug Examplesmentioning
confidence: 99%
“…Serum from patients with cancer has been shown to inhibit neutrophil chemotaxis [20] and phagocytosis. [21] Which of these processes has a larger contribution to the development of malignancies is unknown. Whether it is an inherent defect in neutrophil cytotoxicity allowing malignancies to develop or rather the cancers' ability to impair neutrophils that is primarily responsible for carcinogenesis has yet to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Serum from patients with cancer has been shown to inhibit neutrophil chemotaxis 20 and phagocytosis. 21 Which of these processes has a larger contribution to the development of malignancies is unknown. Whether it is an inherent defect in neutrophil cytotoxicity allowing malignancies to develop or rather the cancers' ability to impair neutrophils that is primarily responsible for carcinogenesis has yet to be determined.…”
Section: Discussionmentioning
confidence: 99%